LEVETIRACETAM DEXCEL 750

Țară: Israel

Limbă: engleză

Sursă: Ministry of Health

Cumpara asta acum

Prospect Prospect (PIL)
22-11-2021

Ingredient activ:

LEVETIRACETAM

Disponibil de la:

DEXCEL PHARMA TECHNOLOGIES LTD

Codul ATC:

N03AX14

Forma farmaceutică:

TABLETS

Compoziție:

LEVETIRACETAM 750 MG

Calea de administrare:

PER OS

Tip de prescriptie medicala:

Required

Produs de:

DEXCEL LTD, ISRAEL

Grupul Terapeutică:

LEVETIRACETAM

Zonă Terapeutică:

LEVETIRACETAM

Indicații terapeutice:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Data de autorizare:

2018-03-31

Documente în alte limbi

Prospect Prospect arabă 22-11-2021
Prospect Prospect ebraică 09-10-2023

Căutați alerte legate de acest produs

Vizualizați istoricul documentelor